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Developmental Regulation of Sensory Neurite Growth by the
Tumor Necrosis Factor Superfamily Member LIGHT
Nu´ria Gavalda`, Humberto Gutierrez, and AlunM. Davies
School of Biosciences, Cardiff University, Cardiff CF10 3US, United Kingdom
In a PCR screen to identify novel cytokine candidates involved in neuronal development, we identified transcripts for the tumor necrosis
factor superfamily member 14 (TNFSF14), generally known as LIGHT (lymphotoxin-related inducible ligand that competes for glyco-
protein D binding to herpesvirus entrymediator on T cells), together with its receptors, lymphotoxin- receptor (LTR) and TNF family
receptor herpesvirus entrymediator (HVEM), in the experimentally tractable sensory neurons of themouse nodose ganglion. Immuno-
cytochemistry revealed coexpression of LIGHT and its receptors in all nodose ganglion neurons in neonates. Enhancing LIGHT signaling
in these neurons by overexpressing LIGHT inhibited BDNF-promoted neurite growth during a narrow window of development in the
immediateperinatal periodwithout affectingneuronal survival.Overexpressing aLIGHTmutant that selectively activatesHVEM,butnot
one that selectively activates LTR, also inhibited BDNF-promoted growth, suggesting that neurite growth inhibition is mediated via
HVEM. Blocking HVEM signaling by a function-blocking anti-HVEM antibody significantly enhanced neurite growth from nodose
neurons grown both with and without BDNF. Likewise, neurons from LIGHT-deficient neonates exhibited significantly greater neurite
growth thanneurons fromwild-type littermates in both thepresence andabsence ofBDNF. LIGHToverexpression significantly inhibited
NF-Bactivity,while preventingLIGHT-inducedNF-B inhibitionbyoverexpressing thep65 andp50NF-Bsubunits preventedLIGHT-
mediated growth inhibition. Together, these findings show that LIGHT/HVEM signaling negatively regulates neurite growth fromdevel-
oping sensory neurons via NF-B inhibition.
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Introduction
Numerous locally acting and diffusible signaling molecules con-
trol the growth and guidance of axons to their targets as well as
terminal arborization within their targets. These molecules bind
to receptors on the advancing axons to influence growth rate,
direction and branching, and are derived from a wide variety of
cells en route to and within their final targets. Many of the mol-
ecules that influence the growth and morphology of neural pro-
cesses also regulate neuronal survival, notably, neurotrophic fac-
tors of the neurotrophin, GDNF, and gp130 cytokine families
(Davies, 2003). Recently, several members of the tumor necrosis
factor superfamily (TNFSF) have been implicated in regulating
the growth of neural processes. Most strikingly, a GITRL/GITR
autocrine loop in sympathetic neurons has been shown to be
crucial for NGF-promoted axonal growth, but not survival, dur-
ing a brief developmental window in the immediate postnatal
period (O’Keeffe et al., 2008).
The 19 members of the TNFSF play critical roles in the devel-
opment and function of the immune system, and are recognized
increasingly as having diverse roles in other tissues and organs
(Hehlgans and Pfeffer, 2005). These cytokines are, for the most
part, expressed as type II transmembrane glycoproteins that are
active as membrane-bound ligands and as soluble ligands after
cleavage from the cell membrane by the action of specific metal-
loproteinases. TNFSF ligands bind to one or more members of
the TNF receptor superfamily (TNFRSF)which are classified into
three groups: those containing a proapoptotic death domain,
those lacking a death domain, and a group of decoy receptors that
do not transmit any signal (Grivennikov et al., 2006).
In a PCR screen for additional members of the TNFSF in-
volved in regulating neuronal development, we found transcripts
for LIGHT (also known as TNFSF14) and its receptors TNF fam-
ily receptor herpesvirus entry mediator (HVEM) (TNFRSF14)
and lymphotoxin- receptor (LTR) (TNFRSF3) in the perinatal
mouse nodose ganglion, a population of enteroceptive sensory
neurons thatmostly depends onBDNF for survival at this stage of
development both in vitro (Davies et al., 1993) and in vivo
(ElShamy and Ernfors, 1997). Although a decoy receptor for
LIGHT, DcR3, has been described in humans, the existence of a
mouse homolog has not been described and is considered un-
likely (Gommerman and Browning, 2003; Bossen et al., 2006).
LIGHT has multiple functions in the immune system and has
been implicated in the regulation of cell proliferation and survival
in several tissues and organs (Ware, 2005; Murphy et al., 2006;
Pierer et al., 2007), but has no known role in the nervous system.
HVEM and LTR lack death domains and interact with adaptors
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of the TRAF family to modulate several signaling pathways in-
cluding the NF-B transcription family (Grivennikov et al.,
2006), which has been implicated in regulating neurite growth
from neonatal nodose ganglion neurons (Gutierrez et al., 2005;
Gallagher et al., 2007). Here we report a novel function for
LIGHT as a negative regulator of neurite growth in nodose sen-
sory neurons by a mechanism involving the HVEM receptor and
NF-B signaling inhibition.
Materials andMethods
Real-time PCR quantification of mRNA levels. Total RNA was extracted
with the RNeasy Mini extraction kit (Qiagen) from nodose ganglion,
superior cervical ganglion (SCG), trigeminal ganglion, hippocampus and
cortex obtained fromneonatal CD-1mice as well as from embryonic and
postnatal CD-1 mice but only from nodose ganglion. RNA was reverse
transcribed for 1 h at 45°C with the AffinityScript kit (Stratagene) in a 25
l reaction according to the manufacturer’s instructions. We amplified
2.5 l aliquots of the reverse transcriptase reaction in a 25 l reaction
volume using the Brilliant QPCR core reagent kit (Stratagene). The re-
spective forward and reverse primers for real-time PCR were: LIGHT,
5-TGG GCA ATC TTC AAA TCA G-3 and 5-GCA TCA GAA GCA
TAA ATA CC-3; HVEM, 5-GTC TAC TAC GTT GTG TCC ATC C-3
and 5-GTCTTGTCACCCAGAATTTGTTC-3; LTR, 5GTCGCTG
GTC CTC-3 and 5-GAA ATG TGG GTC GGC TCT TG-3; GAPDH,
5-AAG GAA AGT GTC AGA GTT G-3 and 5-ACC CTG CTT GTA
TTGGAA-3. For LIGHTPCR a specific beaconwas used (5-CGCGAC
CTC GCT CCT GGG CTC CAT CGC G-3) and for HVEM PCR a
Taqman was also used (5-AGG CTG TCT CCT CCT CGG TCT CAG-
3). PCR was performed with a Mx3000P (Stratagene) and the reactions
were as follow: 45 cycles of 95°C for 30 s, 57°C for 1 min (for LTR) or
51°C (forGAPDH), and 72°C for 30 s, and 50 cycles of 95°C for 30 s, 55°C
(forHVEM) or 50°C (for LIGHT) for 1min, and 72°C for 30 s. Amelting
curve was obtained for LTRPCRproduct after each run to confirm that
the signal corresponded to a unique amplicon of the predicted size. Be-
cause beacon and Taqman were used for LIGHT and HVEM PCR, re-
spectively, the resulting signal was taken as the specific product.
Standard curves were generated in every 96-well plate for every real-
time PCR run by using serial threefold dilutions of a reverse transcribed
RNA from a thymus of CD-1 mouse embryo. All values obtained were
normalized to GAPDH. Three separate dissections were performed for
each age, and each sample was run in triplicate.
Neuron cultures. Dissociated cultures of nodose neurons were estab-
lished from CD1 wild-type mice or from LIGHT/ and LIGHT/
C57BL/6 littermates. Neurons were plated in defined, serum-free me-
dium (Ham’s F-14 containing 0.25% Albumax, Invitrogen), on a poly-
ornithine/laminin substratum in 35 mm tissue culture dishes (Davies et
al., 1993). All animal work was approved by Cardiff University Ethical
Review Board for Animal Research and performed under the 1986 Ani-
mal Procedures Act with personal and project licenses granted by the
Home Office, UK.
Ballistic transfection of dissociated neurons was performed using a
hand-held gene gun (Helios Gene-gun, Bio-Rad) as previously described
(Gutierrez et al., 2005). After transfection, 2 ml of defined medium with
10 ng/ml BDNFwas added to the cells. Neuron survival was quantified as
previously described (Gutierrez et al., 2005). The neurite arbors of trans-
fected neurons were visualized by expression of yellow fluorescent pro-
tein (YFP). In nontransfection experiments, neurite arbors were labeled
with the fluorescent dye calcein-AM (Invitrogen) at the end of the exper-
iment. For every condition in each experiment, images of at least 50
neurons were digitally acquired by confocal microscopy and were ana-
lyzed to obtain total neurite length, number of branch points and Sholl
profiles as previously described (Gutierrez and Davies, 2007). Pairwise
comparisonsweremade using Student’s t test. Formultiple comparisons,
ANOVA was carried out, followed by Fisher’s post hoc test.
Immunocytochemistry. Cultured neurons were fixed in ice-cold meth-
anol for 10 min, washed three times with phosphate-buffered saline
(PBS) and blockedwith 5%BSA in PBS for 1 h at room temperature. The
cells were incubated overnight at 4°C with primary antibody in 1% BSA
(anti--III tubulin, 1:1000, Promega; anti-LIGHT, anti-HVEMand anti-
LTR, 1:50 Santa Cruz). After three washes, the cells were incubatedwith
Alexa-Fluor-labeled secondary antibody (Invitrogen, 1:500) for 1 h. All
cultures were counterstained with DAPI (Chemicon). Controls (second-
ary antibody alone) were included in all studies.
Immunohistochemistry. Nodose ganglia and SCG were dissected from
neonatal pups and fixed in formalin for 2 h followed by cryoprotection in
10% sucrose and embedding in OCT before being frozen and serially
sectioned at 20 m. The sections were immunostained on glass slides as
described above and examined by confocal microscopy. To compare the
levels of LIGHTand its receptors in the nodose ganglion, vagus nerve and
SCG, these structures were sectioned together in the same block andwere
mounted side by side on the same slides for immunostaining.
Quantification of NF-B activity.The relative level of NF-B activation
was estimated by transfecting neurons with a plasmid that expresses GFP
under the control of an NF-B promoter as described previously (Guti-
errez et al., 2005). Between 40 and 60 neurons were imaged for each
experimental condition and all imaging and quantification was per-
formed blind. Statistical comparisons were performed using simple
ANOVA followed by Fisher’s post hoc test.
Results
Expression of LIGHT and its receptors, LTR and HVEM, in
developing neurons
To identify novel candidate members of the TNFSF involved in
neuronal development, we carried a real-time PCR screen for
expression of all TNFSF and TNFRSF members in three exten-
sively studied, experimentally tractable populations of peripheral
nervous system neurons of developing mice and in several CNS
regions. This screen revealed distinctive patterns of expression of
transcripts for LIGHT and its receptors LTR and HVEM in the
nodose ganglia, trigeminal ganglia and superior cervical ganglia
(SCG) and in the hippocampus and frontal cortex of newborn
(P0)mice (Fig. 1A).Whereas the levels of LIGHTmRNA relative
to the housekeeping GAPDH mRNA in peripheral ganglia were
not significantly different, the levels of LTRmRNA and HVEM
mRNA relative to GAPDH mRNA were significantly higher in
nodose ganglia compared with other ganglia. Immunohisto-
chemical localization of LIGHT, LTR and HVEM in sections of
the nodose ganglia and SCG confirmed expression of these pro-
teins and, in accordance with the observed differences in the
expression of HVEM and LTR mRNAs between these ganglia,
revealed noticeably more intense HVEM and LTR immunore-
activity in nodose ganglia (Fig. 1B). The vagus nerve onwhich the
nodose ganglion is located and which contains the axons of no-
dose neurons also displayed clear immunoreactivity for LIGHT,
LTR and HVEM (Fig. 1B). It is worth noting that the rostral
pole of the P0 nodose ganglion contains a group of neurons that
belongs to the much smaller petrosal ganglion that fuses with the
nodose ganglion earlier in development. Immunohistochemical
staining performed on sections passing through this region re-
vealed no differences in immunoreactivity for LIGHT, LTR and
HVEM between nodose and petrosal neurons (data not shown).
Whereas examination of high-power images of the above im-
munohistochemical preparations of the nodose ganglion and va-
gus nerve indicated expression of LIGHT, LTR and HVEM in
the cell bodies and processes of neurons, we used immunocyto-
chemistry to confirm the cellular distribution of these proteins in
dissociated cell cultures established from the nodose ganglia of
newborn mice. These studies revealed that the cell bodies and
processes of all neurons in these cultures (positively identified
with anti-III tubulin antibodies) were labeled by specific anti-
bodies to LIGHT, HVEM and LTR, and that none of the non-
neuronal cells were labeled by these antibodies (Fig. 1C). No cells
were labeled when primary antibodies were omitted from either
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Figure 1. LIGHT, HVEM, and LTR are differentially expressed in the developing nervous system. A, Quantification of the relative levels of LIGHT, HVEM, and LTRmRNAs in total RNA extracted
fromnodose ganglia (ND), superior cervical ganglia (SCG), trigeminal ganglia (TG), hippocampus (HP), and cortex (CX) of P0mice by real-timePCR. The levels of thesemRNAswere calculated relative
to GAPDHmRNA and normalized to a value of 1.0 for the nodose data. Means SEM of assays performed on RNA extracted from three separate sets of tissue, (*p 0.05 and **p 0.01 indicate
statistically significant difference between the indicated bar and all other bars). B, Immunohistochemical localization and relative levels of expression of LIGHT, HVEM, and LTR in sections of P0
nodose ganglia, vagus nerve, and SCG. Scale bars, 50 m. C, Photomicrographs of representative fields of dissociated cultures of P0 nodose neurons that were (Figure legend continues.)
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the immunohistochemical or immunocytochemical protocols
(data not shown), and nodose neurons cultured from LIGHT-
deficient newborn mice were not labeled by the anti-LIGHT an-
tibody (Fig. 1C). The selective expression of LIGHT, HVEM and
LTR in all nodose neurons suggests that each neuron coex-
presses LIGHT and its receptors. Real time PCR revealed that the
levels of LIGHT, HVEM and LTRmRNAs remained fairly con-
stant, relative to GAPDHmRNA, from E15 to P5 in nodose gan-
glia (Fig. 1D).
LIGHT overexpression impairs BDNF-promoted neurite
growth from nodose neurons
Given the relatively high levels of expression of the LIGHT recep-
tors HVEM and LTR in developing nodose neurons, we began
investigating the functions of LIGHT signaling by transfecting
these cells with a LIGHT expression plasmid to examine the con-
sequences of enhancing LIGHT signaling. P0 nodose neurons
were transfected with either a LIGHT expression plasmid or an
empty control pcDNA3.1 plasmid 2 h after plating, and the sur-
vival of the transfected neurons together with the size and com-
plexity of their neurite arbors were quantified after 24 h incuba-
tion inmedium containing BDNF.More than 80%of transfected
neurons were surviving at this time, and there was no significant
difference in the number of LIGHT overexpressing neurons and
control transfected neurons (supplemental Fig. 1A, available at
www.jneurosci.org as supplemental material). Although LIGHT
overexpression had no effect on neuronal survival in the presence
of BDNF, it caused a marked, highly significant reduction on the
number of branch points (Control: 39 2; LIGHT: 22 2) and
neurite arbor length (Control: 2794 112 m; LIGHT: 1459
131m). Sholl analysis, which provides a graphic representation
of branching with distance from the cell body, showed that the
neurite arbors of LIGHT-overexpressing neurons were much
smaller and less complex than those of control transfected neu-
rons (Fig. 2A). The typical appearance of LIGHT-transfected and
control-transfected neurons is shown in Figure 2B.
To determine whether the inhibitory effect of LIGHT overex-
pression on BDNF-promoted neurite growth is restricted to a
particular phase of development, we performed transfection ex-
periments on cultured nodose neurons obtained from mouse
embryos and neonates of different ages. Quantification of neurite
length (Fig. 2C) and branch point number (Fig. 2D) 24 h after
transfection revealed that LIGHT overexpression had no signifi-
cant effect on neurite size and complexity in E16 and P3 cultures,
but caused highly significant reductions in length and branching
in E18 and P0 cultures that were greatest at P0 (44% and 48%
lower than in control-transfected neurons, respectively) These
results demonstrate that the effect of LIGHT overexpression on
neurite growth is restricted to the immediate perinatal period,
and rule out any nonspecific detrimental effects of LIGHT over-
expression on neurite growth (because no decreases were ob-
served before and after this period of development).
Figure 2. A–D, LIGHT overexpression impairs BDNF-promoted neurite growth from nodose
neurons during a developmental window. Dissociated cultures of P0 nodose neurons were
transfected 3 h after platingwith a YFP expression plasmid togetherwith either a LIGHT expres-
sion plasmid (LIGHT) or an empty control plasmid (control). After a further 24 h incubation in
medium containing BDNF (10 ng/ml), confocal images of neurite arborswere acquired for Sholl
analysis (A). Representative control-transfected and LIGHT-overexpressing neurons are shown
inB (Scale bar, 50m). C,D, Nodose neurons from E16, E18, P0, and P3mice were transfected
and cultured as described for A, and B above. Total neurite length (C) and number of branch
points (D) were determined 24 h after transfection, and control data were normalized to 100%
at each age to facilitate comparison of the effects of LIGHT overexpression at different ages. The
combined results of 10 separate experiments at each age are plotted (means and SEs of the data
from 500 neurons for each data point). Statistically significant difference with control-
transfected neurons: **p 0.01, ***p 0.001.
4
(Figure legend continued.) cultured for 24 h inmedium containing 10 ng/ml BDNF before being
triple labeled with either anti--III tubulin, anti-LIGHT, and DAPI (top row), anti--III tubulin,
anti-HVEM, and DAPI (second row), or anti--III tubulin, anti-LTR, and DAPI (third row). The
lower row shows a representative nodose neuron cultured from a P0 LIGHT-deficient mouse
stained for anti--III tubulin, anti-LIGHT, and DAPI. Scale bar, 50m. D, Quantification of the
relative levels of LIGHT, HVEM, and LTRmRNAs in total RNA extracted from nodose ganglia of
E15, E18, P0, and P5mice by real-time PCR. The levels of these mRNAs were calculated relative
to GAPDH mRNA and normalized to a value of 1.0 at the P0 age point (mean SEM of assays
performed on RNA extracted from three separate sets of ganglia at each age).
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Although neonatal SCG neurons express much lower levels of
HVEM and LTR than nodose neurons, we also tested the effects
of overexpressing LIGHT in these neurons. This had no signifi-
cant effect on either number of branching points (control-
transfected neurons, 16  1; LIGHT-overexpressing neurons,
14  1) or total neurite length (control-transfected neurons,
1760  123 m; LIGHT-overexpressing neurons, 1894  199
m). Accordingly, Sholl profiles of control-transfected neurons
and LIGHT-overexpressing neurons were not significantly dif-
ferent (data not shown).
HVEMmediates the effect of LIGHT on BDNF-promoted
neurite growth from nodose neurons
To determine which of the two coexpressed LIGHT receptors
mediate the neurite growth inhibitory effect of LIGHT, we trans-
fected P0 nodose neurons with plasmids that express LIGHT
mutants that selectively activate either LTR or HVEM. LIGHT-
R228Ehas an arginine to glutamic acid substitution at amino acid
228 that causes it to selectively bind and activate LTR (Chen et
al., 2003), whereas LIGHT-G119E has glycine to glutamic acid
substitution at amino acid 119 that causes it to selectively bind
and activate HVEM (Rooney et al., 2000). Neurons expressing
the LIGHT-R228E mutant had neurite arbors that were not sig-
nificant different from those of control-transfected neurons in
terms of overall length (Fig. 3A) or Sholl profiles (Fig. 3B) after
24 h incubation with BDNF, suggesting that LTR does not me-
diate the neurite growth inhibitory effects of LIGHT. In contrast,
expression of the LIGHT-G119E mutant caused highly signifi-
cant reductions in neurite length and complexity (Fig. 3A,B),
suggesting that HVEM mediates the neurite growth inhibitory
effects of LIGHT.Neither LIGHT-G119E nor LIGHT-R228E had
an effect on cell survival (supplemental Fig. 1B, available at
www.jneurosci.org as supplemental material).
To provide supporting evidence for the requirement of
HVEM in mediating the neurite growth inhibitory effect of
LIGHT, we tested whether an anti-HVEM function-blocking an-
tibody interferes with the neurite growth inhibitory effect of
overexpressing LIGHT. P0 nodose neurons were transfectedwith
the LIGHT plasmid and were incubated with BDNF for 24 h in
the presence and absence of anti-HVEM. The length and com-
plexity of the neurite arbors of LIGHT-overexpressing neurons
treated with the anti-HVEM antibody were significantly greater
than LIGHT-overexpressing neurons not treated with this anti-
body (Fig. 3C,D), reinforcing the importance of HVEM inmedi-
ating the neurite growth inhibitory effect of LIGHT.
Endogenous HVEM signaling exerts a neurite growth
inhibitory effect on nodose neurons
Our demonstration that enhancing LIGHT-HVEM signaling in
neonatal nodose neurons inhibits BDNF-promoted neurite
growth begged the question whether endogenous LIGHT-
HVEM signaling exerts an inhibitory influence on the growth of
neurites from these neurons. To investigate this, we cultured P0
nodose neurons with and without the function-blocking anti-
HVEM antibody for 24 h in the presence of different concentra-
tions of BDNF and in the absence of this neurotrophin. To pre-
vent the death of neurons grownwithout BDNF or in suboptimal
concentrations of BDNF, the broad-spectrum, irreversible
caspase inhibitor Boc-D-FMKwas added to all cultures. Neurons
treated with the anti-HVEM antibody had significantly longer,
more complex neurite arbors than untreated neurons in both the
absence of BDNF and in the presence of BDNF at the subsaturat-
ing concentrations of 0.1 and 1 ng/ml (Fig. 4). Anti-HVEM did
Figure 3. HVEMmediates the inhibitory effect of LIGHT on BDNF-promoted neurite growth
fromnodoseneurons.A,B, Dissociated cultures of P0nodoseneuronswere transfected 3h after
platingwith a YFP expression plasmid together with a plasmid expressing either LIGHT, LIGHT-
R228E, or LIGHT-G119E or with an empty control plasmid (control). After a further 24 h incuba-
tion in medium containing BDNF (10 ng/ml), confocal images of neurite arbors were acquired
for calculation of total neurite length (A) and Sholl analysis (B). C, D, Dissociated cultures of P0
nodose neuronswere transfected 3 h after platingwith a YFP expression plasmid togetherwith
either a LIGHT expression plasmid or an empty control plasmid. After a further 24 h incubation
inmedium containing BDNF (10 ng/ml) with andwithout anti-HVEM blocking antibody (1:50),
confocal images of neurite arbors were acquired for calculation of total neurite length (C) and
Sholl analysis (D). The combined data from three separate experiments of each kind are plotted
(means and SEs of the data from150 neurons for each data point). Statistically significant
difference with control-transfected neurons: ***p 0.001 (A). Statistically significant differ-
ence with LIGHT-transfected neurons: ****p 0.0001 (C).
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not, however, significantly increase the Sholl profiles of neurons
grownwith the saturating BDNF concentration of 10 ng/ml (data
not shown). There were no significant differences in the numbers
of neurons surviving under all conditions in these experiments
(supplemental Fig. 1C, available at www.jneurosci.org as supple-
mental material). Together, these results suggest that endoge-
nous HVEM signaling exerts an inhibitory effect on neurite
growth where the concentration of BDNF is limiting.
LIGHT-deficient neurons exhibit enhanced neurite growth
in culture
To investigate further the significance of endogenous LIGHT-
HVEM signaling in regulating neurite growth, we established
dissociated cultures nodose neurons fromLIGHT-deficient new-
born mice and wild-type littermates. For these experiments,
LIGHT/ mice were crossed to generate LIGHT/ and
LIGHT/ pups. Separate nodose neuron cultures were estab-
lished from each newborn pup, and neuronal survival and neu-
rite arbor size and complexity were quantified after 24 h incuba-
tion with and without BDNF at concentrations of 0.1 ng/ml and
1 ng/ml. These data were obtained before the genotypes of the
pups were determined to avoid any possible observe bias. All
cultures received the caspase inhibitor Boc-D-FMK to prevent the
death of neurons grown with suboptimal levels of BDNF and
without this neurotrophin. Neuron counts confirmed that there
were no significant differences in neuronal survival between
wild- type and LIGHT-deficient neurons in all experimental con-
ditions after 24 h incubation (supplemental Fig. 1D, available at
www.jneurosci.org as supplementalmaterial). The neurite arbors
of LIGHT-deficient neurons were significantly longer and more
branched than those of wild-type neurons in both the presence
and absence of BDNF (Fig. 5). As was the case with the anti-
HVEMantibody experiments, the effects of LIGHTdeficiency on
neurite growth were proportionately greater in cultures lacking
BDNF. These results show that endogenously synthesized LIGHT
exerts an inhibitory effect on neurite growth from the nodose
neurons of newborn mice that is especially pronounced in the
absence of BDNF or low BDNF concentrations.
LIGHT inhibits neurite growth by inhibiting NF-B signaling
in nodose neurons
Recent work has shown that NF-B signaling makes an impor-
tant contribution to BDNF-promoted neurite growth and is es-
sential for CNTF-promoted neurite growth from newborn
mouse nodose neurons (Gutierrez et al., 2005, 2008; Gallagher et
al., 2007). BecauseNF-B plays amajor role inmediating cellular
responses to members of the TNFSF (Grivennikov et al., 2006),
we studied the effect of LIGHT signaling on NF-B transcrip-
tional activity in nodose neurons and tested whether this plays a
role inmediating the neurite growth inhibitory effects of LIGHT.
The level ofNF-B transcriptional activity in nodose neuronswas
measured by transfecting these cells with a reporter construct in
which GFP expression is under the control of a B binding regu-
latory element (Gutierrez et al., 2005). The fluorescence signal
from this reporter was 73% lower in neurons cotransfected with
the LIGHT expression plasmid compared with neurons cotrans-
fected with an empty control expression plasmid (Fig. 6A). This
suggests that enhancing LIGHT signaling in nodose neurons in-
hibits NF-B in these cells. To determine which receptor medi-
ates NF-B inhibition by LIGHT, we cotransfected nodose neu-
rons with the NF-B reporter and either of the two receptor-
specific LIGHT mutants. Whereas expression of LIGHT-G119E
mutant caused amarked reduction in reporter signal (90% lower
Figure 4. A–D, Endogenous HVEM signaling exerts a neurite growth inhibitory effect on
nodose neurons. Dissociated cultures of P0 nodose neurons were incubated with and without
anti-HVEMblocking antibody (1:50) inmediumcontaining the caspase inhibitor Boc-D-FMK (25
M) and either no BDNF, 0.1 ng/ml BDNF, or 1 ng/ml BDNF. After 24 h incubation the neurons
were labeled with calcein-AM and confocal images of neurite arbors were acquired for calcula-
tionof total neurite length (A) andSholl analysis (B–D). The combineddata fromthree separate
experiments of each kind are plotted (means and SEs of the data from150 neurons for each
data point). Statistically significant differences in neurite length in cultures with and without
anti-HVEM: **p 0.01, ***p 0.001.
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than in control transfected neurons), expression of the LIGHT-
R228E mutant had no effect on the reporter signal (Fig. 6A),
implying that LIGHT inhibits NF-B in neurons by acting via
HVEM. As a positive control for NF-B inactivation in these
experiments, we cotransfected nodose neurons with the NF-B
reporter and double stranded DNA oligonucleotides containing
the B consensus binding sequence that compete for activated
NF-B and prevent its binding to B regulatory elements (Mor-
ishita et al., 1997). As expected, this B decoy DNA, but not
scrambled control DNA (data not shown), caused a very marked
reduction in reporter signal similar to those observed in neurons
overexpressing LIGHT or LIGHT-G119E (Fig. 6A).
To determine whether LIGHT-induced NF-B inactivation is
required for the growth inhibitory effect of LIGHT, we cotrans-
fected nodose neurons with the LIGHT-G119E plasmid together
with plasmids expressing the p65 and p50 NF-B subunits to
enhance NF-B transcriptional activity (Gutierrez et al., 2008)
and counter LIGHT-induced NF-B inactivation. As expected,
the NF-B reporter signal in LIGHT-G119E expressing neurons
overexpressing p65 and p50was significantly greater than in con-
trol transfected neurons (Fig. 6A). Finally, to determine whether
this reversal in NF-B transcriptional activity prevented LIGHT-
induced neurite growth inhibition, we compared the size and
complexity of the neurite arbors of neurons transfected with the
LIGHT-G119E plasmid and neurons transfected with this plas-
mid in combination with p65 and p50 plasmids. After 24 h incu-
bation in medium containing BDNF, there were no significant
differences in the size and complexity of the neurite arbors of
control-transfected neurons and neurons transfected with the
LIGHT-G119E plasmid in combination with p65 and p50 plas-
mids (Fig. 6B,C), indicating that overexpression of p65 and p50
completely prevented the neurite growth inhibitory effect of
LIGHT-G119E. Representative examples of control-transfected
neurons and neurons expressing LIGHT-G119E alone or in com-
binationwith overexpressed p65 andp50 are shown in Figure 6D.
Together, these results demonstrate that LIGHT inactivates
NF-B signaling by an HVEM-dependent mechanism, and that
this inhibition is required for the neurite growth inhibitory ef-
fects of LIGHT.
Discussion
Wehave discovered that LIGHT, amember of the TNFSFwith no
previously described function in the nervous system, acting via its
receptor HVEM is a potent negative regulator of neurite growth
from neonatal nodose ganglion neurons. These neurons coex-
press LIGHT and both its signaling receptors HVEM and LTR
during the period of development when the axons of these neu-
rons are ramifying in their peripheral and central targets. Over-
expression of LIGHT in cultured nodose neurons markedly in-
hibits the neurite growth-promoting effects of saturating levels of
BDNF during a narrow developmental window in the immediate
perinatal period. EnhancingHVEMsignaling in these neurons by
expressing a LIGHTmutant that selectively activates HVEM like-
wise markedly inhibits BDNF-promoted neurite growth. In con-
trast, expression of a LIGHT mutant that selectively activates
LTR has no effect on neurite growth, and neither this mutant
nor the HVEM-selective LIGHT mutant have any effect on neu-
ronal survival with or without BDNF. Blocking endogenous
ligand-dependent activation of HVEM in cultured nodose neu-
rons using a function-blocking anti-HVEM antibody enhances
the low level of neurite growth that occurs in the absence of
BDNF and enhances neurite growth from neurons cultured with
subsaturating, but not saturating, levels of BDNF. Likewise,
LIGHT-deficient neurons have significantly larger, more
branched neurite arbors than those of wild-typemice in the pres-
ence and absence of subsaturating levels of BDNF. Together,
these findings indicate that LIGHT-HVEM signaling and BDNF-
Figure 5. A–D, LIGHT-deficient nodose neurons exhibit enhanced neurite growth in culture. Dis-
sociated cultures of P0 nodose neurons were established from LIGHT/ (/) and LIGHT/
(/) littermates andwere incubated inmediumcontainingeither noBDNF, 0.1ng/mlBDNF, or 1
ng/ml BDNF. Themedium in cultures contained the caspase inhibitor Boc-D-FMK (25M). After 24 h
incubation the neurons were labeled with calcein-AM and confocal images of neurite arbors were
acquired for calculation of total neurite length (A) and Sholl analysis (B–D). The combineddata from
three separate experiments of each kindareplotted (means andSEs of thedata from150neurons
for each data point). Statistically significant differences in neurite length between of neurons from
LIGHT/ and LIGHT/mice: *p 0.05, **p 0.01.
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TrkB signaling exert opposing actions on
neurite growth from perinatal nodose
neurons, and that the size and complexity
of the neurite arbors of these neurons is
governed by the relative levels of signaling
in these two ligand-receptor systems.
Whereas nodose neurons obtain BDNF
from target field cells in vivo, the coexpres-
sion of LIGHT andHVEM in nodose neu-
rons suggests that LIGHT-HVEM signal-
ing is activated by either an autocrine
mechanism within individual neurons or
by a paracrine mechanism between neu-
rons.Whether acting by autocrine or para-
crine mechanisms, the basal level of
LIGHT-HVEM signaling in nodose neu-
rons could play a role in reducing or re-
stricting terminal axon growth and
branching from neurons that are less suc-
cessful in the competition for target-
derived BDNF in vivo. In this way, LIGHT-
HVEM signaling may be involved in
facilitating the elimination of superfluous
or inappropriate axon terminals during
the later stages of target field innervation.
The presence of LIGHT and HVEM in the
intact vagus nerve and along the neurites
of cultured nodose neurons raises the pos-
sibility that LIGHT-HVEM interaction
could occur between the distal branches of
sensory axons. In addition to autocrine
and/or paracrine activation of HVEM by
LIGHT on developing sensory axons, it is
possible that LIGHT produced by a variety
of other cell types could play a role in the
local regulation of axonal growth and
branching in vivo. Likewise, although our
finding that anti-HVEMdoes not enhance
neurite growth from LIGHT-deficient no-
dose neurons (data not shown) suggests
that LIGHT is the only functionally rele-
vant HVEM ligand in our in vitro para-
digm, this does not preclude the possibility
that LT-3, the other TNFSF ligand for
HVEM, may act on nodose neurons in
vivo. Our demonstration that LIGHT and
HVEM are also expressed in at least two
other peripheral ganglia and in the devel-
oping hippocampus and cortex raises the
possibility that HVEM may play a role in
regulating the growth of neural processes
elsewhere in the nervous system. Although
preliminary studies in neonatal SCG neu-
rons, which express much lower levels of
HVEM than nodose neurons, have not
provided evidence for a role for LIGHT in regulating neurite
growth from these neurons, our positive data from extensive
studies of nodose neurons set the president for exploring the role
of HVEM and its ligands in regulating the growth of neural pro-
cesses elsewhere in the nervous system.
We have demonstrated that enhanced LIGHT-HVEM signal-
ing potently inhibits NF-B signaling in neonatal nodose neu-
rons. This finding contrasts with numerous previous studies in a
wide variety of cell types that have reported that LIGHT, acting
via eitherHVEMor LTR, activatesNF-B (Marsters et al., 1997;
Hikichi et al., 2001; Matsui et al., 2002; Zou andHu, 2005;Wei et
al., 2006; Pierer et al., 2007). We have previously shown that
NF-B is a key regulator of neurite growth in neonatal nodose
neurons, and that inhibiting canonical NF-B signaling in these
neurons significantly reduces BDNF-promoted neurite growth
during a developmental window from E18 to P1 (Gutierrez et al.,
Figure 6. LIGHT inhibits neurite growth by inhibiting NF-B signaling in nodose neurons.A, Dissociated cultures of P0 nodose
neurons were transfected 3 h after platingwith an RFP plasmid and theB-GFP reporter together with either the LIGHT plasmid,
LIGHT-G119E plasmid, LIGHT-R228E plasmid, LIGHT-G119E, p65, and p50 plasmids in combination, an empty control plasmid
(control), orBdecoyDNA.After a further 18h incubation inmediumcontainingBDNF (10ng/ml) the intensity of theGFP reporter
signal was quantified in transfected neurons (positively identified by RFP fluorescence). B–D, Dissociated cultures of P0 nodose
neuronswere transfected3hafter platingwith aYFPplasmid togetherwith the LIGHT-G119Eplasmid, the LIGHT-G119E, p65, and
p50plasmids in combination, or anempty control plasmid. After a further 24h incubation inmediumcontainingBDNF (10ng/ml),
confocal images of neurite arbors were acquired for calculation of total neurite length (B) and Sholl analysis (C). D, Photomicro-
graphs of a representative control-transfected neuron, a LIGHT-G119E expressing neuron, and a LIGHT-G119E expressing neuron
inwhich p65 and p50 are overexpressed (Scale bar, 50m). The combined data from three separate experiments of each kind are
plotted. Statistically significant differences with controls: **p  0.01, ****p  0.0001 compared with control transfected
neurons.
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2005). Interestingly, the inhibitory effect of LIGHT overexpres-
sion on BDNF-promoted neurite growth is restricted to a similar
developmental window. Our demonstration that circumventing
LIGHT-induced NF-B inactivation by overexpressing the p50
andp65NF-B subunits during thiswindow completely prevents
LIGHT-induced neurite growth inhibition, suggests that
LIGHT-induced NF-B inactivation is the mechanism by which
LIGHT negatively regulates BDNF-promoted neurite growth.
Together, these observations suggest that the developmental win-
dow over which LIGHT inhibits neurite growth is governed by
the developmentally restricted requirement for NF-B signaling
in neurite growth rather than by developmental changes in the
expression of LIGHT and/or HVEM.
Several recent reports have implicatedmembers of the TNFSF
and their receptors in neurite growth regulation. FasL promotes
neurite growth from DRG explants (Desbarats et al., 2003) and
increases neurite branching from cultured hippocampal and cor-
tical neurons (Zuliani et al., 2006). FN14 overexpression en-
hances neurite growth from in PC12 cells (Tanabe et al., 2003).
TNF inhibits neurite growth fromhippocampal neurons in cul-
ture (Neumann et al., 2002), but paradoxically the dendritic ar-
bors of these neurons are smaller in TNF-deficient mice in vivo
(Golan et al., 2004). TROY can substitute for p75NTR in the
Nogo receptor complex that mediates the effects of myelin-
associated neurite growth inhibitory factors (Shao et al., 2005).
Most recently, a GITRL-GITR signaling loop in developing sym-
pathetic neurons has been shown to be crucial for NGF-
promoted axon growth in vitro and the establishment of sympa-
thetic innervation in vivo (O’Keeffe et al., 2008). Our current
study provides the first evidence for a role for LIGHT-HVEM
signaling in the nervous system and supports the growing real-
ization that TNFSF is extensively involved in regulating the
growth of neural processes during development.
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